[左旋多巴联合脱羧酶抑制剂治疗帕金森综合征。II] - Suppr

Suppr

超能文献

[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].

作者信息

Gauthier G, de Ajuriaguerra J, Simona B, Constantinidis J, Eisenring J J, Krassoievitch M, Yanniotis G, Tissot R

出版信息

Rev Neurol (Paris). 1970 Nov;123(5):297-319.

PMID:5513630

Abstract

摘要

相似文献

[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].[左旋多巴联合脱羧酶抑制剂治疗帕金森综合征。II]

Rev Neurol (Paris). 1970 Nov;123(5):297-319.

[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].

Rev Med Chil. 1973 Jun;101(6):452-5.

[L-DOPA-and dopa-decarboxylase inhibitor combination for the treatment of Parkinsonism].左旋多巴与多巴脱羧酶抑制剂联合治疗帕金森病

Nihon Rinsho. 1974 Mar;32(3):579-86.

L-Dopa, B 6 , and alpha-methyldopa hydrazine.左旋多巴、维生素B6和α-甲基多巴肼。

Confin Neurol. 1973;35(3):186-92.

Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism.帕金森病中的脑脊液单胺代谢产物与外周脱羧酶抑制剂

Neurology. 1970 Dec;20(12):Suppl:36-40.

[Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].口服左旋多巴联合脱羧酶抑制剂（Ro IV 46.02）治疗帕金森综合征

Presse Med (1893). 1969 Apr 5;77(17):619-22.

[Therapy of parkinsonian syndromes and plasmatic DOPA levels. Effects of L-DOPA and 3-OMD, administered alone or combined, with or without a decarboxylase inhibitor].

Rev Eur Etud Clin Biol. 1972 Jan;17(1):38-44.

Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602.

Scand J Rehabil Med. 1974;6(2):89-93.

Therapeutic uses and side effects of L-dopa.

Adv Intern Med. 1972;18:219-49.

[Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].

Munch Med Wochenschr. 1973 Apr 20;115(16):711-3.

引用本文的文献

The pharmacology of Parkinson's disease: basic aspects and recent advances.帕金森病的药理学：基础方面与最新进展

Experientia. 1984 Nov 15;40(11):1165-72. doi: 10.1007/BF01946641.

Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease.左旋多巴联合外周脱羧酶抑制用于帕金森病治疗

Can Med Assoc J. 1972 Jun 10;106(11):1169-74.

Parkinson's disease and striatal dopamine: in vivo morphological evidence for the presence of dopamine in the human brain.帕金森病与纹状体多巴胺：人脑中存在多巴胺的体内形态学证据

J Neural Transm. 1974;35(1):13-22. doi: 10.1007/BF01245332.

[Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)].

Psychopharmacologia. 1973 Oct 23;33(1):95-101. doi: 10.1007/BF00428797.

[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

Arch Psychiatr Nervenkr (1970). 1973 Mar 19;217(1):95-112. doi: 10.1007/BF02552835.

Brocresine in Parkinson's disease. Action of a peripheral and central decarboxylase inhibitor in potentiating levodopa.布罗克辛在帕金森病中的作用。一种外周和中枢脱羧酶抑制剂增强左旋多巴的作用。

J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):27-9. doi: 10.1136/jnnp.36.1.27.

Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.用左旋多巴和脱羧酶抑制剂治疗帕金森病。

Z Neurol. 1972;202(1):1-20. doi: 10.1007/BF00316422.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验